[{"Assets_0_Q1_USD":"4596717000.0","CIK":"1048477","CommonStockSharesIssued_0_Q1_shares":"176653480.0","CommonStockSharesOutstanding_0_Q1_shares":"176653480.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.25","EarningsPerShareDiluted_1_Q1_USD":"-0.26","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-42509000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-44149000.0","NetIncomeLoss_1_Q1_USD":"-44149000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q1_USD":"373447000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"2807003000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"176150000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"175932000.0","filed":"20180427","footnote":null,"form":"10-Q","fp":"Q1","fy":"2018.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20180331","qtrs":"0","uom":"USD"}]